FSD Pharma Inc.
NASDAQ:HUGE
0.0899 (USD) • At close August 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0.197 | 0.065 | 0.021 | 0 | 0 |
| Cost of Revenue
| 2.552 | 4.358 | 4.01 | 4.107 | 2.039 | 0 | 0 | 0 | 0 |
| Gross Profit
| -2.552 | -4.358 | -4.01 | -4.107 | -1.843 | 0.065 | 0.021 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | -9.362 | 1 | 1 | 0 | 0 |
| Reseach & Development Expenses
| 3.93 | 6.911 | 6.328 | 7.833 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 11.968 | 15.981 | 23.37 | 18.11 | 22.862 | 16.134 | 2.823 | 0.03 | 0.033 |
| Selling & Marketing Expenses
| 13.435 | 0 | 0 | 0 | 0 | 2.058 | 0 | 0 | 0 |
| SG&A
| 13.447 | 15.981 | 23.37 | 18.11 | 22.862 | 18.193 | 2.823 | 0.03 | 0.033 |
| Other Expenses
| 0 | 4.537 | 4.046 | 4.658 | 3.117 | -0.402 | 0 | 0 | 0 |
| Operating Expenses
| 17.377 | 27.43 | 33.744 | 30.601 | 25.979 | 18.622 | 2.823 | 0.03 | 0.033 |
| Operating Income
| -19.929 | -27.43 | -33.744 | -30.691 | -28.072 | -20.44 | -2.803 | -0.03 | -0.033 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | -142.63 | -313.645 | -135.86 | 0 | 0 |
| Total Other Income Expenses Net
| 1.364 | 0.726 | -0.194 | 2.239 | -11.746 | 1.883 | 0 | 0 | 0 |
| Income Before Tax
| -18.565 | -26.704 | -33.938 | -28.452 | -39.818 | -16.674 | -2.803 | -0.03 | -0.033 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | -202.308 | -255.859 | -135.86 | 0 | 0 |
| Income Tax Expense
| -0 | -3.382 | 1.468 | 4.267 | 0.235 | -3.766 | -0.053 | -0.023 | 0 |
| Net Income
| -18.565 | -23.322 | -35.406 | -32.719 | -40.053 | -16.674 | -2.803 | -0.03 | -0.033 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | -203.503 | -255.859 | -135.86 | 0 | 0 |
| EPS
| -0.47 | -0.6 | -1.01 | -2.72 | -5.68 | -2.82 | -0.43 | -0.005 | -0.005 |
| EPS Diluted
| -0.47 | -0.6 | -1.01 | -2.72 | -5.68 | -2.82 | -0.43 | -0.005 | -0.005 |
| EBITDA
| -17.377 | -22.405 | -29.647 | -26.017 | -25.335 | -20.305 | -2.803 | -0.03 | -0.033 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | -128.723 | -311.581 | -135.86 | 0 | 0 |